In its Q1 17 trading update (reports only sales numbers), Reckitt Benckiser reported it weakest results in the last 15 years with lfl sales growth turning flat (below consensus estimate of +1% and vs. 5% and 1% in Q1 and Q4 16, respectively), underperforming close peers Unilever: 2.9% underlying growth and P&G: +1% during the quarter. On a segmental basis, Health remained flat (Scholl / Amope impact) while Home and Portfolio segments contracted 4% and 6%, respectively, marred by the South

01 Jun 2017
Weak Q1 renders FY 17 growth aspirations challenging

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Weak Q1 renders FY 17 growth aspirations challenging
Reckitt Benckiser Group plc (RKT:LON) | 6,154 1353.9 0.4% | Mkt Cap: 44,063m
- Published:
01 Jun 2017 -
Author:
Jyoti Prakash -
Pages:
3 -
In its Q1 17 trading update (reports only sales numbers), Reckitt Benckiser reported it weakest results in the last 15 years with lfl sales growth turning flat (below consensus estimate of +1% and vs. 5% and 1% in Q1 and Q4 16, respectively), underperforming close peers Unilever: 2.9% underlying growth and P&G: +1% during the quarter. On a segmental basis, Health remained flat (Scholl / Amope impact) while Home and Portfolio segments contracted 4% and 6%, respectively, marred by the South